Concepedia

Stimulant and Anticataplectic Effects of Reboxetine in Patients with Narcolepsy: A Pilot Study

Oscar Larrosa, Yolanda de la Llave, Soledad Barrio, Juan José Granizo, Diego García‐Borreguero

SLEEP · 2001 · 80 citations · 7 references

DOIFull text

Open access

Abstract

Our results suggest that reboxetine exerts stimulant and anticataplectic effects in narcolepsy. Contrary to previous thinking, by which stimulant action would require dopaminergic facilitation, noradrenergic mechanisms might be relevant to the control of wakefulness.

References

7

The International Classification of Sleep Disorders: Diagnostic and Coding Manual

Annals of Internal Medicine · 1991 · 2.4K citations

, , +7

The International Classification of Sleep Disorders

Donald W. Greenblatt · Archives of Neurology · 1992 · 1.6K citations

, , +19

Value of the Multiple Sleep Latency Test (MSLT) for the Diagnosis of Narcolepsy

Michael S. Aldrich, Ronald D. Chervin, Beth A. Malow · SLEEP · 1997 · 262 citations · Full text

, , +14

Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.

Seiji Nishino, J Mao, Rhaghaban Sampathkumaran et al. · PubMed · 1998 · 186 citations

, , +22

Narcolepsy and its treatment with stimulants. ASDA standards of practice.

Merrill M. Mitler, Michael S. Aldrich, G F Koob et al. · PubMed · 1994 · 139 citations

, , +25